Loading organizations...
Enterprise Partners Venture Capital functions as a venture capital firm, primarily providing early-stage capital to emerging companies. It targets innovative businesses across technology and life sciences, including digital media, wireless networks, and specialized energy solutions. The firm typically invests between $3 million and $10 million, often taking board seats and leading investment rounds.
Founded in 1985 in La Jolla, California, Enterprise Partners Venture Capital emerged from an insight into the critical need for early financial and strategic backing for promising startups. Key partners like Thomas Clancy and Drew Senyei played significant roles in shaping its investment philosophy, fostering entrepreneurial endeavors.
The firm's clients are early-stage companies seeking capital and mentorship to scale operations. Enterprise Partners Venture Capital's vision centers on transforming innovative concepts into successful ventures. It strives to be a crucial partner, enabling founders to achieve growth potential and contribute to advancements in technology and life sciences.
Enterprise Partners Venture Capital has 3 tracked investments across 2 companies. The latest tracked deal is $39.0M Series E in Complete Genomics in August 2010.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 1, 2010 | Complete Genomics | $39.0M Series E | Sands Capital | OrbiMed, Highland Capital Management, OVP Venture Partners, Prospect Venture Partners |
| Oct 1, 2009 | VMix | $2.0M Series B | — | ATA Ventures, JK&B Capital, Mission Ventures |
| Aug 1, 2009 | Complete Genomics | $45.0M Series D | — | OrbiMed, Highland Capital Management, OVP Venture Partners, Prospect Venture Partners |
